AxoGen (AXGN) Misses Q1 EPS by 2c

AxoGen (NASDAQ: AXGN) reported Q1 EPS of ($0.15), $0.02 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $23.3 million versus the consensus estimate of $22.33 million.

For earnings history and earnings-related data on AxoGen (AXGN) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• B.Riley on Nayax (NYAX): 'Sell-Off Overshoots the Story'
• AnaptysBio, Inc. (ANAB) Tops Q2 EPS by 524c